Evofem Biosciences is revolutionizing women’s sexual and reproductive healthcare with a first-in-class innovative hormone-free contraceptive and STI prevention compound in development. Launched in 2020, FDA-approved Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel is a first-in-class hormone-free, on-demand prescription contraception that a woman can control. To find out more visit www.evofem.com and www.phexxi.com. Phexxi® is a registered trademark of Evofem Biosciences.